Amgen Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Amgen Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 97% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 7.4 times. Higher than 92% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$162Over the last 3 years, every $100 of reported profit came with $162 of operating cash.
Higher than 57% of Healthcare companies in United States.
Self-Funding Ratio
7.4×Over the last 3 years its own operating cash covered its investment spending (capex) 7.4 times.
Higher than 92% of Healthcare companies in United States.
Cash Locked Ratio
$32For every $100 of sales, $32 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $28 tied up three years earlier.
More money tied up than 69% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$11Sales grew 40% in 3 years; of every extra $100 of sales, $11 became extra profit.
Lower than 58% of Healthcare companies in United States.
Asset Productivity Ratio
+40% / +39%In 3 years sales changed by +40% while total assets changed by +39%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
2.2×Debt due within a year is covered 2.2 times by its yearly operating cash.
Higher than 74% of Healthcare companies in United States.
Cash Cushion Ratio
−19%Debt, after subtracting cash, equals 19% of its market value (net debt).
Lower than 83% of Healthcare companies in United States.
Tangible Assets Ratio
55%Of every $100 the company owns, $55 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 74% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 97% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Amgen Inc. owes $0.88 for every $1 it owns. Net profit rose 89% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
27.8Investors pay $27.8 for every $1 of Amgen Inc.'s yearly profit, higher than 53% of Healthcare companies in United States.
P/B ratio
20.69The share price is 20.69 times Amgen Inc.'s book value per share, higher than 94% of Healthcare companies in United States.
Market cap
$241.8 BThe total market value of all of Amgen Inc.'s shares at today's price (share price × number of shares), larger than almost all Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$11.7 BWhat Amgen Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$21.62Net worth divided by the number of shares. The share price of $447.28 is 20.7 times this, which is the P/B above.
Return on equity (ROE)
91.5%Amgen Inc. earned 91.5% on its shareholders' money over the last year, higher than 98% of Healthcare companies in United States.
Owes vs Owns
0.88×Amgen Inc. owes $0.88 for every $1 it owns (high), higher than 82% of Healthcare companies in United States.
Dividend yield
2.30%Amgen Inc. pays 2.30% of its share price as dividends a year, higher than 82% of dividend-paying Healthcare companies in United States.
Revenue growth
+10%Revenue rose 10% in the year to Dec 2025, and grew 12% a year on average over 3 years.
Profit growth
+89%Net profit rose 89% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Profit margin
21.0%Amgen Inc. keeps $21 of every $100 of revenue as net profit.
Cash quality
1.3×Cash from Amgen Inc.'s business was 1.3× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
3.3×Amgen Inc.'s operating profit covered its interest costs 3.3 times in the year to Dec 2025.
Cash vs debt
Net debtAmgen Inc. had $45.5 B more debt than cash (net debt) at Dec 2025.
Questions
What is Amgen Inc.'s P/E ratio?
Investors pay $27.8 for every $1 of Amgen Inc.'s yearly profit, higher than 53% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Amgen Inc.: $241.8 B ÷ $11.7 B (30 Jun 2026) = 20.7.
What is Amgen Inc.'s return on equity?
Amgen Inc. earned 91.5% on its shareholders' money over the last year, higher than 98% of Healthcare companies in United States.
How much does Amgen Inc. owe compared with what it owns?
Amgen Inc. owes $0.88 for every $1 it owns (high), higher than 82% of Healthcare companies in United States.
Does Amgen Inc. pay a dividend?
Yes. Amgen Inc. pays 2.30% of its share price as dividends a year, higher than 82% of dividend-paying Healthcare companies in United States.
Is Amgen Inc.'s revenue growing?
Revenue rose 10% in the year to Dec 2025, and grew 12% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.